Ma Jichun, Kubota Fumie, Yoshimura Masato, Yamashita Eiki, Nakagawa Atsushi, Ito Akio, Tsukihara Tomitake
Institute for Protein Research, Osaka University, Japan.
Acta Crystallogr D Biol Crystallogr. 2004 Feb;60(Pt 2):317-9. doi: 10.1107/S0907444903025770. Epub 2004 Jan 23.
Monoamine oxidase (MAO) is an FAD-containing mitochondrial outer-membrane protein which catalyzes the degradation of several neurotransmitters in the central nervous system. The two subtypes of MAO, MAOA and MAOB, have similar primary sequences but different substrate and inhibitor specificities. The structure of human MAOB has recently been determined, but the structure of MAOA remains unknown. To clarify the mechanisms underlying their unique substrate and inhibitor recognition and thereby facilitate the development of new specific inhibitors to treat MAO-related neurological disorders, rat MAOA was crystallized in a complex with the specific inhibitor clorgyline. Diffraction data were collected to 3.2 A resolution. The crystal belongs to the space group P4(3)2(1)2, with unit-cell parameters a = b = 158.2, c = 258.4 A.
单胺氧化酶(MAO)是一种含黄素腺嘌呤二核苷酸(FAD)的线粒体外膜蛋白,它催化中枢神经系统中几种神经递质的降解。MAO的两种亚型,MAOA和MAOB,具有相似的一级序列,但底物和抑制剂特异性不同。人源MAOB的结构最近已被确定,但MAOA的结构仍然未知。为了阐明其独特的底物和抑制剂识别机制,从而促进开发治疗与MAO相关的神经疾病的新型特异性抑制剂,大鼠MAOA与特异性抑制剂氯吉兰形成复合物后结晶。收集了分辨率为3.2 Å的衍射数据。该晶体属于空间群P4(3)2(1)2,晶胞参数a = b = 158.2,c = 258.4 Å。